# Acadia Healthcare Announces First Quarter 2026 Results
Canonical URL: https://biopharmsignal.com/news/ACHC/acadia-healthcare-announces-first-quarter-2026-results
Ticker: ACHC
Company: Acadia Healthcare
Source: Acadia Healthcare
Published: 2026-04-29 20:05 EST
Original Source URL: https://acadiahealthcare.gcs-web.com
## Summary

Company Increases Full Year 2026 Adjusted EBITDA and Adjusted EPS Guidance FRANKLIN, Tenn. --(BUSINESS WIRE)--Apr. 29, 2026-- Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2026.

## Article Body
Company Increases Full Year 2026 Adjusted EBITDA and Adjusted EPS Guidance FRANKLIN, Tenn. --(BUSINESS WIRE)--Apr. 29, 2026-- Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2026.
## Recent Company News
- 2026-04-29 20:05 EST — [Acadia Healthcare Announces First Quarter 2026 Results](https://biopharmsignal.com/news/ACHC/acadia-healthcare-announces-first-quarter-2026-results) — Source: Acadia Healthcare
- 2026-04-23 20:15 EST — [Acadia Healthcare Appoints David Duckworth as Interim Chief Financial Officer](https://biopharmsignal.com/news/ACHC/acadia-healthcare-appoints-david-duckworth-as-interim-chief-financial-officer) — Source: Acadia Healthcare
- 2026-04-08 14:00 EST — [Acadia Healthcare Announces Date for First Quarter 2026 Earnings Release](https://biopharmsignal.com/news/ACHC/acadia-healthcare-announces-date-for-first-quarter-2026-earnings-release) — Source: Acadia Healthcare
- 2026-03-12 20:15 EST — [Acadia Healthcare Appoints Daniel Cancelmi to Board of Directors](https://biopharmsignal.com/news/ACHC/acadia-healthcare-appoints-daniel-cancelmi-to-board-of-directors) — Source: Acadia Healthcare
- 2026-02-25 12:00 EST — [Acadia Healthcare Announces Fourth Quarter and 2025 Results](https://biopharmsignal.com/news/ACHC/acadia-healthcare-announces-fourth-quarter-and-2025-results) — Source: Acadia Healthcare
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)